Makino Masahiko, Mukai Tetsu
Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Nihon Hansenbyo Gakkai Zasshi. 2012 Sep;81(3):199-203. doi: 10.5025/hansen.81.199.
To activate naïve T cells convincingly using Mycobacterium bovis BCG (BCG), rBCG (BCG-D70M) that was deficient in urease, expressed with gene encoding the fusion of BCG-derived heat shock protein (HSP) 70 and Mycobacterium leprae-derived major membrane protein (MMP)-II, one of the immunodominant Ags of M. leprae, was newly constructed. BCG-D70M was more potent in activation of both CD4+ and CD8+ subsets of naïve T cells than rBCGs including urease-deficient BCG and BCG-70M secreting HSP70-MMP-II fusion protein. BCG-D70M efficiently activated dendritic cells (DC) to induce cytokine production and phenotypic changes, and activated CD4+ T cells even when macrophages were used as APCs. The activation of both subsets of T cells was MHC and CD86 dependent. Pre-treatment of DC with chloroquine inhibited both surface expression of MMP-II on DC and the activation of T cells by BCG-D70M-infected APCs. The naïve CD8+ T cell activation was inhibited by treatment of DC with brefeldin A and lactacystin so that the T cells was activated by TAP- and proteosome-dependent cytosolic cross-priming pathway. From naïve CD8+ T cells, effector T cells producing perforin and memory T cells having migration markers, were produced by BCG-D70M stimulation. BCG-D70M primary infection in C57BL/6 mice produced T cells responsive to in vitro secondary stimulation with MMP-II and HSP70, and more efficiently inhibited the multiplication of subsequently challenged M. leprae than vector control BCG. These results indicate that the triple combination of HSP70, MMP-II and urease depletion may provide useful tool for inducing better activation of naïve T cells.
为了使用牛分枝杆菌卡介苗(BCG)令人信服地激活初始T细胞,新构建了重组卡介苗(rBCG,BCG-D70M),其缺乏脲酶,并表达了编码卡介苗来源的热休克蛋白(HSP)70与麻风分枝杆菌来源的主要膜蛋白(MMP)-II(麻风分枝杆菌的免疫显性抗原之一)融合的基因。与包括缺乏脲酶的BCG和分泌HSP70-MMP-II融合蛋白的BCG-70M在内的rBCG相比,BCG-D70M在激活初始T细胞的CD4+和CD8+亚群方面更有效。BCG-D70M能有效激活树突状细胞(DC)以诱导细胞因子产生和表型变化,并且即使将巨噬细胞用作抗原呈递细胞(APC)时也能激活CD4+ T细胞。T细胞两个亚群的激活均依赖于主要组织相容性复合体(MHC)和CD86。用氯喹预处理DC可抑制DC上MMP-II的表面表达以及BCG-D70M感染的APC对T细胞的激活。用布雷菲德菌素A和乳胞素处理DC可抑制初始CD8+ T细胞的激活,从而使T细胞通过抗原加工相关转运体(TAP)和蛋白酶体依赖性胞质交叉呈递途径被激活。通过BCG-D70M刺激,从初始CD8+ T细胞产生了产生穿孔素的效应T细胞和具有迁移标记的记忆T细胞。在C57BL/6小鼠中进行BCG-D70M初次感染产生了对MMP-II和HSP70体外二次刺激有反应的T细胞,并且比载体对照BCG更有效地抑制了随后攻击的麻风分枝杆菌的增殖。这些结果表明,HSP70、MMP-II和脲酶缺失的三联组合可能为诱导初始T细胞更好的激活提供有用工具。